Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ruolun Wei"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract The intricate interplay between cancer cells and their surrounding microenvironment has emerged as a critical factor driving the aggressive progression of various malignancies, including gliomas. Among the various components of this dynamic
Externí odkaz:
https://doaj.org/article/93bd4f6b87f24a5888462038f5b63fd7
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
IntroductionGliomas are the most prevalent primary malignant intracranial tumors, characterized by high rates of therapy resistance, recurrence, and mortality. A major factor contributing to the poor prognosis of gliomas is their ability to diffusely
Externí odkaz:
https://doaj.org/article/102269e7b1084c0e99c844f9905250e3
Publikováno v:
Metabolites, Vol 14, Iss 3, p 160 (2024)
Imprint Desorption Electrospray Ionization Mass Spectrometry Imaging (IDESI-MSI) has proven to be a robust and reliable tool for chemically imaging biological samples such as fungi, animal tissues, and plants, but the choice of the imprint substrate
Externí odkaz:
https://doaj.org/article/949818b3a9934c75b74513af9072d32e
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Purpose The aim of this study was to investigate the epidemiological characteristics and associated risk factors of recurrent lower-grade glioma [LGG] (WHO grades II and III) according to the 2016 updated WHO classification paradigm and fina
Externí odkaz:
https://doaj.org/article/255f27da415a44a386f189f6b09425b3
Autor:
Ruolun Wei, Wei, Xinting
TMZ monotherapy is associated with malignant recurrent behavior in diffuse adult-type lower grade gliomas.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b8b07692da4322486a2754703d51bd
Publikováno v:
BMC Cancer
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Purpose The aim of this study was to investigate the epidemiological characteristics and associated risk factors of recurrent lower-grade glioma [LGG] (WHO grades II and III) according to the 2016 updated WHO classification paradigm and finally devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cab45e4da3e5db118356a738fbd2549e
https://pubmed.ncbi.nlm.nih.gov/35086512
https://pubmed.ncbi.nlm.nih.gov/35086512